Inequitable access to neurosurgical care in the United States

• by Linda Liverani, Nina Dwumfour-Poku, Corinna C. Zygourakis, Silvia D. Vaca

• June 18, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min

Artificial intelligence in neurovascular surgery: advancing diagnosis, treatment, and outcomes

• by Liping Li, Zhonghua Zhang, Lin Zong

• June 18, 2026

Effect of training on navigated frameless and frame-based stereotactic brain biopsies: a retrospective comparison of staff neurosurgeon and trainee perioperative performance and complications

• by H. Joswig, S. H. Nestle, J. M. Funk, S. Sultanova, C. Doenitz, T. Seyfried, J. Augustin, F. Grassmann, U. Träger, S. Blecha

• June 12, 2026